Author

Bora Yeon

Institution: Korea Institute of Drug Safety and Risk Management

Observed institution: Korea Institute of Drug Safety and Risk Management

ORCID: 0000-0001-8734-6714

Observed ORCID: 0000-0001-8734-6714

OpenAlex ID: A5016202444

Aneurysm and Artery Dissection After Oral VEGFR-TKI Use in Adults With Cancer

2023 · Soyoung Kang, Bora Yeon, et al. · JAMA Network Open · 11

Depression risk associated with the use of 5α-reductase inhibitors versus α-blockers: A retrospective cohort study in South Korea

2022 · Bora Yeon, Ah Young Suh, et al. · PLoS ONE · 8

Risk of incident diabetes after initiation of 5α-reductase inhibitor plus α-blocker combination therapy: A nationwide cohort study with age-specific analyses

2026 · Eonji Na, Bora Yeon, et al. · Diabetes Research and Clinical Practice

Use of Hydroxychloroquine and Occurrence of Cardiac Disease and Death in South Korea

2025 · Nayeong Son, Youjin Jang, et al. · Journal of Pharmacoepidemiology and Risk Management

Hydrochlorothiazide Use and the Risk of Non-Melanoma Skin Cancer in Hypertensives: A Nested Case-Control Study

2025 · Bora Yeon, Ah Young Suh, et al. · Journal of Pharmacoepidemiology and Risk Management

Works count: 5

Citation count: 19

H-index: 2

I10-index: 1